Uncategorized Archives - Page 5 of 248

MondayJul 15, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Replicate Results from First GLP-1 Study Following CRO Contract Award for 12-Week Chronic Human Study

Lexaria, a global innovator in drug delivery platforms, recently hired a contract research organization (“CRO”) for its upcoming chronic human study, GLP-1-H24-4 This study will seek to evaluate various glucagon-like peptide-1 (“GLP-1”) formulations, processed with the company’s patented DehydraTECH(TM) technology The study will feature five arms, with each conducted using several investigational sites in Australia Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the hiring of a contract research organization (“CRO”) that will be responsible for overseeing the execution of the company’s upcoming chronic human study, GLP-1-H24-4. This 12-week study will seek to evaluate various…

FridayJul 12, 2024 10:00 am

Thai Marijuana Advocates Protest Plans to Outlaw Substance Again

In June 2022, Thailand made the decision to decriminalize marijuana, making it the first country in southeast Asia to do so. The campaign to decriminalize the drug was spearheaded by Anutin Charnvirakul of the Bhumjaithai Party. Anutin, who headed the Ministry of Health in 2022, called for an amendment to be made to the Narcotics Law. This subsequently led to marijuana being eliminated from Thailand’s list of controlled substances. While the drug was intended solely for medicinal use with the law also allowing private recreational use, the market remained unregulated. This allowed recreational use to flourish but increased public concerns…

FridayJul 12, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Dedicated to Creating Unparalleled Tech, Labs, Facilities and Teams in Cannabis Space

MedCana offers a long list of proprietary essential services to its clients The company’s team of pharmaceutical scientists includes some of the world’s most respected chemists From initial grow to final product, MedCana helps partners produce pharmaceutical CBD and other extracts that have no equal As the cannabis industry prepares to enter a new era with a pending schedule change in the Controlled Substances Act (“CSA”), Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is committed to being a worldwide force for high-quality cannabis products. To achieve this lofty goal, the company is focused on building the technology, laboratories, growing facilities,…

WednesdayJul 10, 2024 9:45 am

The 5th Annual NECANN New Jersey Cannabis Convention Projected to Witness Mammoth Turnout

The NECANN New Jersey Cannabis Convention will be held in partnership with 420NJevents at the Atlantic City Convention Center, September 6-7. As the NECANN family continues to grow every year, the turnout this year is expected to cross 4,000+ attendees with 200 exhibitors showcasing their innovative business ideas. The NECANN New Jersey Cannabis Convention has developed robust networking and business connections since its first event in 2019. The convention will be attended by influential canna traders, license holders, dispensary owners, suppliers, investors, ancillary industries, and industry leaders from the East Coast and beyond. New Jersey has a thriving cannabis market,…

TuesdayJul 09, 2024 4:20 pm

420 with CNW — NCAA Removes Cannabis from List of Banned Substances

Marijuana will no longer be prohibited for Division 1 athletes following a vote by the National Collegiate Athletic Association (NCAA). The decision comes approximately five months after the association’s Division I Council recommended the change. The new policy highlights that cannabis should be viewed similarly to alcohol because it isn’t a performance-enhancing substance. Further, the change follows a 2022 policy revision that increased the allowable THC levels for college athletes, bringing the NCAA’s rules in line with the World Anti-Doping Agency (WADA). The new rule modifies the NCAA’s drug-testing guidelines for student-athletes participating in postseason football and sports championships, applying…

FridayJun 28, 2024 9:45 am

Golden Triangle Ventures Inc. (GTVH) Announces Full Financial Support to Launch Freight Brokerage Division

Cargo Management Group acquisition includes a full-fledged logistics operation, brokerage business, licenses and all associated assets Acquisition helps move GTVH toward goal of becoming a highly profitable company with minimal to zero debt and a diverse asset portfolio Along with acquisition, company receives full financial support from T&K Zarro to fund key components of new venture In a strategic move that aligns with the company’s vision “to assemble a strong portfolio of successful businesses under one overarching umbrella” (https://cnw.fm/HWyV8), Golden Triangle Ventures (OTC: GTVH) (“GTV”) has announced a full-service freight brokerage business designed to significantly expand its logistics capabilities (https://cnw.fm/rMOmx).…

WednesdayJun 26, 2024 9:45 am

Software Effective Solutions Corp. (SFWJ) Partners with Leading Colombian Company as Global Cannabis Opportunities Increase

“A myriad of opportunities has emerged for (cannabis) investors, entrepreneurs and enthusiasts worldwide,” reports Newsweek MedCana’s agreement to begin exporting CBD buds to Switzerland appears to be particularly timely The company noted that this new collaboration marks a “significant milestone” in the company’s expansion into the European market Interest in cannabis is growing globally, and savvy companies operating in the cannabis space, such as Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), are working to strengthen their positions. Most recently, MedCana announced a new strategic partnership between one of its subsidiaries and a prominent Colombian company to begin export of its…

WednesdayJun 26, 2024 9:00 am

Golden Triangle Ventures Inc. (GTVH), Largest Note Holder Reach Agreement That Will Enhance Shareholder Value

GTVH enters pivotal agreement with largest note holder, T&K Zarro LLC CEO notes that agreement demonstrates “our commitment to strengthening our capital structure and delivering tangible value to our shareholders” The agreement is a “testament” to the company’s strategic foresight and dedication to fostering a robust and scalable business model Golden Triangle Ventures (OTC: GTVH) continues momentum as the company announces strategic steps in its commitment to solidifying its capital structure, expanding its business operations and enhancing shareholder value. Most recently, the company revealed a pivotal agreement with T&K Zarro LLC, GTVH’s largest note holder (https://cnw.fm/3mhs9). “This agreement marks a…

MondayJun 24, 2024 12:45 pm

CannaCon Midwest St. Paul To Move the Midwest Cannabis Industry Forward

CannaCon Midwest St. Paul invites like-minded entrepreneurs, investors, public officials, patients, and enthusiasts of the cannabis spectrum, to attend the CannaCon Midwest St. Paul conference August 16-17, 2024. This event is a one-stop solution for the cannabis community looking for resources, education, and collaboration opportunities, for all things cannabis. The CannaCon conference offers a phenomenal platform for enthusiasts, creatives, growers, and traders in and around the venue, to stay updated with the latest industry trends and develop the best networking connections. They will find the latest cultivation techniques, genetics, supplies, unique industry innovations, business, financial, and legal advice, marketing, branding…

MondayJun 24, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Second Round of Dosing for Human Pilot Study #2; Set to Complete Third Study Arm in Early July

Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration The study’s main objective is to evaluate Lexaria’s patented DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug, semaglutide, currently commercially available as Rybelsus(R) The commencement of the pilot study shows Lexaria’s commitment to its promise to focus on GLP-1 studies for 2024, along with its confidence in its…